Open Heart · 2021 · 48 citations · 22 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical EpidemiologyMolecular PathologyCardiovascular DiseaseHeart FailureAmyloid FibrilsClinical Cohort IdentificationClinical Red FlagsHeart Failure EpidemiologyRetrospective Case StudySymptom Assessment In Cardiomyopathy
OBJECTIVE: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive and fatal condition caused by deposition of transthyretin amyloid fibrils in the heart. This study aims to identify all patients diagnosed with ATTR-CM in Sweden, estimate the prevalence of ATTR-CM, describe patient characteristics and mortality, assess the importance of early symptoms (red flags) for identification of ATTR-CM, and compare with patients with heart failure (HF). METHODS: This retrospective study combined multiple national health registers covering all specialist visits and prescriptions for the entire population of Sweden. Between January 2008 and December 2018, patients with ATTR-CM were identified retrospectively based on a combination of diagnosis codes and compared with matched, all-cause non-ATTR HF patients. RESULTS: Overall, a total of 994 patients diagnosed with ATTR-CM were identified, with an average age at diagnosis of 73 years, and 30% of whom were female. The prevalence of diagnosed ATTR-CM cases in 2018 was 5.0 per 100 000. The median survival from diagnosis was 37.6 months (CI 33.8 to 43.8), with a lower median survival in women (27.9 months, CI 23.3 to 33.8) compared with men (43.5 months, CI 37.6 to 49.6). Patients with ATTR-CM demonstrated reduced survival compared with patients with HF (p<0.001). Compared with patients with HF, clinical identification of carpal tunnel syndrome, spinal stenosis, and atrioventricular and left bundle branch block can facilitate earlier diagnosis of ATTR-CM. CONCLUSIONS: This study provides the first nationwide estimates of ATTR-CM prevalence and risk factors. The results reinforce the severity of the disease and the importance of earlier diagnosis, especially for female patients, in order to allow effective treatment and prevention of disease progression.
22
Comorbidity Measures for Use with Administrative Data
Anne Elixhauser, Claudia Steiner, D.R. Harris et al. · Medical Care · 1998 · 9.9K citations
Education, Health Services Administration, Health Assessment +16
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson, Eva Andersson, Anders Ekbom et al. · BMC Public Health · 2011 · 5.1K citations · Full text
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text
Björn Wettermark, Niklas Hammar, C. MichaelFored et al. · Pharmacoepidemiology and Drug Safety · 2006 · 1.9K citations · Full text
The Swedish cause of death register
Hannah L. Brooke, Mats Talbäck, Jesper Hörnblad et al. · European Journal of Epidemiology · 2017 · 1.4K citations · Full text
Public Health, Population Health Sciences, Clinical Epidemiology +16